WallStSmart

Amdocs Ltd (DOX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Amdocs Ltd stock (DOX) is currently trading at $65.41. Amdocs Ltd PE ratio is 12.65. Amdocs Ltd PS ratio (Price-to-Sales) is 1.54. Analyst consensus price target for DOX is $90.57. WallStSmart rates DOX as Moderate Buy.

  • DOX PE ratio analysis and historical PE chart
  • DOX PS ratio (Price-to-Sales) history and trend
  • DOX intrinsic value — DCF, Graham Number, EPV models
  • DOX stock price prediction 2025 2026 2027 2028 2029 2030
  • DOX fair value vs current price
  • DOX insider transactions and insider buying
  • Is DOX undervalued or overvalued?
  • Amdocs Ltd financial analysis — revenue, earnings, cash flow
  • DOX Piotroski F-Score and Altman Z-Score
  • DOX analyst price target and Smart Rating
DOX

Amdocs

NASDAQTECHNOLOGY
$65.41
$1.72 (2.70%)
52W$63.33
$93.63
Target$90.57+38.5%

📊 No data available

Try selecting a different time range

IV

DOX Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Amdocs Ltd (DOX)

Margin of Safety
+36.1%
Strong Buy Zone
DOX Fair Value
$109.60
Graham Formula
Current Price
$65.41
$44.19 below fair value
Undervalued
Fair: $109.60
Overvalued
Price $65.41
Graham IV $109.60
Analyst $90.57

DOX trades at a significant discount to its Graham intrinsic value of $109.60, offering a 36% margin of safety — a level value investors typically seek before buying.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Amdocs Ltd (DOX) · 10 metrics scored

Smart Score

65
out of 100
Grade: B-
Strong Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in peg ratio, price/sales, institutional own.. Concerns around revenue growth. Overall metrics suggest strong investment potential with favorable risk/reward.

Amdocs Ltd (DOX) Key Strengths (5)

Avg Score: 8.4/10
PEG RatioValuation
0.9610/10

Growing significantly faster than its price suggests

Institutional Own.Quality
100.92%10/10

100.92% of shares held by major funds and institutions

Price/SalesValuation
1.548/10

Paying $1.54 for every $1 of annual revenue

Market CapQuality
$7.06B7/10

Mid-cap company balancing growth potential with stability

Return on EquityProfitability
16.50%7/10

Solid profitability: $17 profit per $100 equity

Supporting Valuation Data

P/E Ratio
12.65
Undervalued
Forward P/E
8.61
Attractive
Trailing P/E
12.65
Undervalued
Price/Sales (TTM)
1.542
Undervalued
EV/Revenue
1.677
Undervalued
DOX Target Price
$90.57
23% Upside

Amdocs Ltd (DOX) Areas to Watch (5)

Avg Score: 4.8/10
Revenue GrowthGrowth
4.10%2/10

Revenue growing slowly at 4.10% annually

EPS GrowthGrowth
9.00%4/10

Modest earnings growth at 9.00%

Operating MarginProfitability
18.90%6/10

Decent operational efficiency, solid but not exceptional

Price/BookValuation
2.046/10

Fairly priced relative to book value

Profit MarginProfitability
12.50%6/10

Decent profitability, keeps $13 per $100 revenue

Amdocs Ltd (DOX) Detailed Analysis Report

Overall Assessment

This company scores 65/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.4/10) while 5 fall into concern territory (avg 4.8/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.

The Bull Case

The strongest argument centers on PEG Ratio, Institutional Own., Price/Sales. Valuation metrics including PEG Ratio (0.96), Price/Sales (1.54) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 16.50%.

The Bear Case

The primary concerns are Revenue Growth, EPS Growth, Operating Margin. Some valuation metrics including Price/Book (2.04) suggest expensive pricing. Growth concerns include Revenue Growth at 4.10%, EPS Growth at 9.00%, which may limit upside. Profitability pressure is visible in Operating Margin at 18.90%, Profit Margin at 12.50%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 16.50% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 4.10% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (PEG Ratio, Institutional Own.) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

DOX Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

DOX's Price-to-Sales ratio of 1.54x sits near its historical average of 1.37x (57th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 21% below its historical high of 1.95x set in Jul 2017, and 171% above its historical low of 0.57x in Feb 2009.

Compare DOX with Competitors

Top SOFTWARE - INFRASTRUCTURE stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Amdocs Ltd (DOX) · TECHNOLOGYSOFTWARE - INFRASTRUCTURE

The Big Picture

Amdocs Ltd is a strong growth company balancing expansion with improving profitability. Revenue reached 4.6B with 410% growth year-over-year. Profit margins of 12.5% are healthy, with room for further expansion as the business scales.

Key Findings

Strong Revenue Growth

Revenue growing at 410% YoY, reaching 4.6B. This pace significantly outperforms most SOFTWARE - INFRASTRUCTURE peers.

Excellent Capital Efficiency

ROE of 1650.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

What to Watch Next

Margin expansion: can Amdocs Ltd push profit margins above 15% as the business scales?

Growth sustainability: can Amdocs Ltd maintain 410%+ revenue growth, or will competition slow it down?

Dividend sustainability with a current yield of 3.6%. Watch payout ratio and free cash flow coverage.

Debt management: total debt of 952M is significantly higher than cash (248M). Monitor refinancing risk.

Bottom Line

Amdocs Ltd offers an attractive blend of growth (410% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Amdocs Ltd(DOX)

Exchange

NASDAQ

Sector

TECHNOLOGY

Industry

SOFTWARE - INFRASTRUCTURE

Country

USA

Amdocs Limited provides software and services to the world's communications, cable and satellite, entertainment and media industry service providers. The company is headquartered in Chesterfield, Missouri.

Visit Amdocs Ltd (DOX) Website
625 MARYVILLE CENTRE DRIVE, SAINT LOUIS, MO, UNITED STATES, 63141